110 related articles for article (PubMed ID: 1436531)
1. Long-term neuromuscular dysfunction produced by passive transfer of amyotrophic lateral sclerosis immunoglobulins.
Uchitel OD; Scornik F; Protti DA; Fumberg CG; Alvarez V; Appel SH
Neurology; 1992 Nov; 42(11):2175-80. PubMed ID: 1436531
[TBL] [Abstract][Full Text] [Related]
2. Immunoglobulins from animal models of motor neuron disease and from human amyotrophic lateral sclerosis patients passively transfer physiological abnormalities to the neuromuscular junction.
Appel SH; Engelhardt JI; García J; Stefani E
Proc Natl Acad Sci U S A; 1991 Jan; 88(2):647-51. PubMed ID: 1988960
[TBL] [Abstract][Full Text] [Related]
3. Immunoglobulins from amyotrophic lateral sclerosis patients enhance spontaneous transmitter release from motor-nerve terminals.
Uchitel OD; Appel SH; Crawford F; Sczcupak L
Proc Natl Acad Sci U S A; 1988 Oct; 85(19):7371-4. PubMed ID: 2902629
[TBL] [Abstract][Full Text] [Related]
4. Amyotrophic lateral sclerosis IgG-treated neuromuscular junctions develop sensitivity to L-type calcium channel blocker.
Fratantoni SA; Weisz G; Pardal AM; Reisin RC; Uchitel OD
Muscle Nerve; 2000 Apr; 23(4):543-50. PubMed ID: 10716765
[TBL] [Abstract][Full Text] [Related]
5. Uptake of immunoglobulin G from amyotrophic lateral sclerosis patients by motor nerve terminals in mice.
Fratantoni SA; Dubrovsky AL; Uchitel OD
J Neurol Sci; 1996 May; 137(2):97-102. PubMed ID: 8782161
[TBL] [Abstract][Full Text] [Related]
6. Passive transfer of purified IgG from patients with amyotrophic lateral sclerosis to mice results in degeneration of motor neurons accompanied by Ca2+ enhancement.
Pullen AH; Demestre M; Howard RS; Orrell RW
Acta Neuropathol; 2004 Jan; 107(1):35-46. PubMed ID: 14551798
[TBL] [Abstract][Full Text] [Related]
7. Neuromuscular transmission in amyotrophic lateral sclerosis.
Maselli RA; Wollman RL; Leung C; Distad B; Palombi S; Richman DP; Salazar-Grueso EF; Roos RP
Muscle Nerve; 1993 Nov; 16(11):1193-203. PubMed ID: 8105377
[TBL] [Abstract][Full Text] [Related]
8. Axonal degeneration, distal collateral branching and neuromuscular junction architecture alterations occur prior to symptom onset in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
Clark JA; Southam KA; Blizzard CA; King AE; Dickson TC
J Chem Neuroanat; 2016 Oct; 76(Pt A):35-47. PubMed ID: 27038603
[TBL] [Abstract][Full Text] [Related]
9. Amyotrophic lateral sclerosis: serum factors enhance spontaneous and evoked transmitter release at the neuromuscular junction.
O'Shaughnessy TJ; Yan H; Kim J; Middlekauff EH; Lee KW; Phillips LH; Kim J; Kim YI
Muscle Nerve; 1998 Jan; 21(1):81-90. PubMed ID: 9427227
[TBL] [Abstract][Full Text] [Related]
10. Amyotrophic lateral sclerosis immunoglobulins increase Ca2+ currents in a motoneuron cell line.
Mosier DR; Baldelli P; Delbono O; Smith RG; Alexianu ME; Appel SH; Stefani E
Ann Neurol; 1995 Jan; 37(1):102-9. PubMed ID: 7818241
[TBL] [Abstract][Full Text] [Related]
11. Immunoglobulin Fc gamma receptor promotes immunoglobulin uptake, immunoglobulin-mediated calcium increase, and neurotransmitter release in motor neurons.
Mohamed HA; Mosier DR; Zou LL; Siklós L; Alexianu ME; Engelhardt JI; Beers DR; Le WD; Appel SH
J Neurosci Res; 2002 Jul; 69(1):110-6. PubMed ID: 12111822
[TBL] [Abstract][Full Text] [Related]
12. Serine proteases purified from sera of patients with amyotrophic lateral sclerosis (ALS) induce contrasting cytopathology in murine motoneurones to IgG.
Demestre M; Howard RS; Orrell RW; Pullen AH
Neuropathol Appl Neurobiol; 2006 Apr; 32(2):141-56. PubMed ID: 16599943
[TBL] [Abstract][Full Text] [Related]
13. Amyotrophic lateral sclerosis-immunoglobulins selectively interact with neuromuscular junctions expressing P/Q-type calcium channels.
Gonzalez LE; Kotler ML; Vattino LG; Conti E; Reisin RC; Mulatz KJ; Snutch TP; Uchitel OD
J Neurochem; 2011 Nov; 119(4):826-38. PubMed ID: 21883225
[TBL] [Abstract][Full Text] [Related]
14. New perspectives on amyotrophic lateral sclerosis: the role of glial cells at the neuromuscular junction.
Arbour D; Vande Velde C; Robitaille R
J Physiol; 2017 Feb; 595(3):647-661. PubMed ID: 27633977
[TBL] [Abstract][Full Text] [Related]
15. Expression of a Mutant SEMA3A Protein with Diminished Signalling Capacity Does Not Alter ALS-Related Motor Decline, or Confer Changes in NMJ Plasticity after BotoxA-Induced Paralysis of Male Gastrocnemic Muscle.
Moloney EB; Hobo B; De Winter F; Verhaagen J
PLoS One; 2017; 12(1):e0170314. PubMed ID: 28103314
[TBL] [Abstract][Full Text] [Related]
16. Cross-disease comparison of amyotrophic lateral sclerosis and spinal muscular atrophy reveals conservation of selective vulnerability but differential neuromuscular junction pathology.
Comley LH; Nijssen J; Frost-Nylen J; Hedlund E
J Comp Neurol; 2016 May; 524(7):1424-42. PubMed ID: 26502195
[TBL] [Abstract][Full Text] [Related]
17. Defects in synaptic transmission at the neuromuscular junction precede motor deficits in a TDP-43
Chand KK; Lee KM; Lee JD; Qiu H; Willis EF; Lavidis NA; Hilliard MA; Noakes PG
FASEB J; 2018 May; 32(5):2676-2689. PubMed ID: 29295857
[TBL] [Abstract][Full Text] [Related]
18. The role of immune processes in amyotrophic lateral sclerosis pathogenesis.
Alexianu ME
Rom J Neurol Psychiatry; 1995; 33(3-4):215-27. PubMed ID: 8729177
[TBL] [Abstract][Full Text] [Related]
19. [Abnormal hyperexcitability in ALS].
Kohara N
Rinsho Shinkeigaku; 1999 Jan; 39(1):61-4. PubMed ID: 10377805
[TBL] [Abstract][Full Text] [Related]
20. Quantitative analysis of monoclonal immunoglobulins in serum of patients with amyotrophic lateral sclerosis.
Duarte F; Binet S; Lacomblez L; Bouche P; Preud'homme JL; Meininger V
J Neurol Sci; 1991 Jul; 104(1):88-91. PubMed ID: 1919600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
